Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials.

Autor: Wieczorek, Aleksandra1 (AUTHOR) a.wieczorek@uj.edu.pl, Manzitti, Carla2 (AUTHOR) carlamanzitti@gaslini.org, Garaventa, Alberto2 (AUTHOR) albertogaraventa@gaslini.org, Gray, Juliet3 (AUTHOR) jcgray@soton.ac.uk, Papadakis, Vassilios4 (AUTHOR) vpapadak@otenet.gr, Valteau-Couanet, Dominique5 (AUTHOR) dominique.valteau@gustaveroussy.fr, Zachwieja, Katarzyna6 (AUTHOR) katarzyna.zachwieja@gmail.com, Poetschger, Ulrike7 (AUTHOR) ulrike.poetschger@ccri.at, Pribill, Ingrid7 (AUTHOR) ingridpr@gmx.at, Fiedler, Stefan8 (AUTHOR) stefan.fiedler@stanna.at, Ladenstein, Ruth8 (AUTHOR) ruth.ladenstein@ccri.at, Lode, Holger N.9 (AUTHOR) holger.lode@med.uni-greifswald.de
Zdroj: Cancers. Apr2022, Vol. 14 Issue 8, p1919. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje